Review sul management dell’HCC
Review article: management of hepatocellular carcinoma.Cabrera R, Nelson DR. Aliment Pharmacol Ther. 2009 Nov 19. [Epub ahead of print] Background Hepatocellular…
Approfondisci...
Caffè riduce rischio di HCC
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.Freedman ND, Everhart JE, Lindsay KL,…
CEUS e RMN nella diagnosi di HCC
The diagnostic and economic impact of contrast imaging technique in the diagnosis of small hepatocellular carcinoma in cirrhosis. Sangiovanni A,…
L’espressione del miR-26 è associata ad un miglior outcome nell’HCC
MicroRNA expression, survival, and response to interferon in liver cancer.Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler…
Utilizzo del sorafenib in attesa del trapianto: un analisi costo-beneficio
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety.Vitale…
Sunitinib nel trattamento dell’HCC
Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies.Zhu AX, Duda DG, Sahani DV, Jain RK.…
Prevenzione della recidiva di HCC con IFN: una review sistematica+ meta-analisi
Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.Breitenstein S, Dimitroulis D,…
HCC : trattamento chirurgico open vs laparoscopico
Laparoscopic and open treatment of hepatocellular carcinoma in patients with cirrhosis.Belli G, Limongelli P, Fantini C, D’Agostino A, Cioffi L,…
Rischio di progressione dell’early HCC dopo RF
Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation.Fernandes ML, Lin CC, Lin CJ, Chen WT, Lin SM.…
Sono applicabili criteri più liberali di selezione per il trapianto nei pazienti con HCC
Liberal selection criteria for liver transplantation for hepatocellular carcinoma.Muscari F, Foppa B, Kamar N, Peron JM, Selves J, Suc B.…
HCC nei pazienti con sindrome metabolica
Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.Paradis V, Zalinski S, Chelbi…
Terapia adiuvante e neoadiuvante associata a chirurgia dell’HCC
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC.…
Radioembolizzazione con ittrio dell’HCC
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.Vente MA, Wondergem M, van der Tweel I, van…
Validazione del BCLC in pazienti con HCC operabile
Validation of the BCLC Prognostic System in Surgical Hepatocellular Cancer Patients.Vitale A, Saracino E, Boccagni P, Brolese A, D’Amico F,…
Fattori predittivi di recidiva di HCC dopo trapianto
Predictive factors of recurrence of hepatocellular carcinoma after liver transplantation: a multivariate analysis.Lai Q, Merli M, Ginanni Corradini S, Mennini…
Nuova meta-analisi su RF vs PEI nell’HCC
Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.Bouza C, Lopez-Cuadrado T, Alcazar R, Saz-Parkinson Z, Amate JM.…
AngioTC migliora la valutazione di progressione dell’HCC
Impact of a unified CT angiography system on outcome of patients with hepatocellular carcinoma Toyoda H, Kumada T, Sone Y.…
